Neoantigenics' Seed VC - II Round

Neoantigenics raised a round of funding on April 12, 2014. Investors include CIT GAP Funds.

Neoantigenics is focused on developing oncology theranostics (therapeutic plus diagnostic) products, founded on the novel science around oocyte (egg)-associated cancer neoantigens discovered at the Un…

Articles about Neoantigenics' Seed VC - II Round: